Evidence map›Paper›PMID 25733914›Full record

ArticleBiochemistry insights2015

Production, Purification, and Identification of Cholest-4-en-3-one Produced by Cholesterol Oxidase from Rhodococcus sp. in Aqueous/Organic Biphasic System.

Ke Wu, Wei Li, Jianrui Song, Tao Li

Open access · diamondAbstract read
In one paragraph

Article in Biochemistry insights, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Natural Products from Octocorals of the GenusMolecules (Basel, Switzerland) · 2020
    Review
  3. Beneficial microbes · 2019
    Article
  4. International journal of molecular sciences · 2019
    Review
  5. Article
  6. Bioprospecting of whole-cell biocatalysts for cholesterol biotransformation.World journal of microbiology & biotechnology · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Simultaneous Determination of Six Active Components inJournal of analytical methods in chemistry · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ke WuCollege of Life Science, Sichuan Normal University, Chengdu, Sichuan, China.
Wei LiCollege of Life Science, Sichuan Normal University, Chengdu, Sichuan, China.
Jianrui SongDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA. ; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Tao LiCollege of Life Science, Sichuan Normal University, Chengdu, Sichuan, China.
Sichuan Normal University · CNUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholest-4-en-3-one has positive uses against obesity, liver disease, and keratinization. It can be applied in the synthesis of steroid drugs as well. Most related studies are focused on preparation of cholest-4-en-3-one by using whole cells as catalysts, but production of high-quality cholest-4-en-3-one directly from cholesterol oxidase (COD) using an aqueous/organic two-phase system has been rarely explored. This study set up an enzymatic reaction system to produce cholest-4-en-3-one. We developed and optimized the enzymatic reaction system using COD from COX5-6 (a strain of Rhodococcus) instead of whole-cell biocatalyst. This not only simplifies and accelerates the production but also benefits the subsequent separation and purification process. Through extraction, washing, evaporation, column chromatography, and recrystallization, we got cholest-4-en-3-one with purity of 99.78%, which was identified by nuclear magnetic resonance, mass spectroscopy, and infrared spectroscopy. In addition, this optimized process of cholest-4-en-3-one production and purification can be easily scaled up for industrial production, which can largely decrease the cost and guarantee the purity of the product.

Indexed as

biphasic systemcholest-4-en-3-oneenzymatic conversionidentificationproductionpurification

Identifiers

PMID25733914
PMCPMC4334050
OpenAlexW2079248135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.